Reported Aug 22, 2018 · Terminated

Valsartan HCTZ, 160/12.5mg, 30 tablets per bottle, Rx Only, Repackaged By: Northwind Pharmaceuticals, Indianapolis, IN…

Northwind Pharmaceuticals LLC

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Northwind Pharmaceuticals LLC · 9402 Uptown Dr Ste 1100 · Indianapolis, IN · 46256-1042

Is this the product you have?

  • Valsartan HCTZ, 160/12.5mg, 30 tablets per bottle, Rx Only
  • Repackaged ByNorthwind Pharmaceuticals, Indianapolis, IN 46256
  • NDC51655-950-52
Lot codes and dates
  • Lot
    • UTB23790003
    • exp 02/28/2019
Amount recalled
43 bottles

This recall covers 4 products

The agency filed one notice per product. You are reading one of them; the other 3 are below.

Where it was sold

Why it was recalled

CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Northwind Pharmaceuticals LLC recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Notice updated Mar 25, 2023 · Data as of Sep 19, 7:19 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.